Robert J. Kelley - 08 Dec 2021 Form 4 Insider Report for Talis Biomedical Corp

Role
Chief Executive Officer, Director
Signature
/s/ J. Roger Moody, Jr., Attorney-in-Fact for Robert J. Kelley
Issuer symbol
TLIS on OTC
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4
Filing time
09 Dec 2021, 15:14:57 UTC
Previous filing
05 Oct 2021
Next filing
02 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock Option (right to buy) Award $0 +450,000 $0.000000 450,000 08 Dec 2021 Common Stock 450,000 $4.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.